Global Viral Vector Manufacturing Market Research Report 2023

Report ID: 1917723 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Viral Vector Manufacturing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Adenoviral Vectors
        1.2.3 Adeno-associated Viral Vectors
        1.2.4 Retroviral Vectors
        1.2.5 Lentiviral Vectors
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Viral Vector Manufacturing Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Gene Therapy
        1.3.3 Vaccinology
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Viral Vector Manufacturing Market Perspective (2017-2028)
    2.2 Viral Vector Manufacturing Growth Trends by Region
        2.2.1 Viral Vector Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Viral Vector Manufacturing Historic Market Size by Region (2017-2022)
        2.2.3 Viral Vector Manufacturing Forecasted Market Size by Region (2023-2028)
    2.3 Viral Vector Manufacturing Market Dynamics
        2.3.1 Viral Vector Manufacturing Industry Trends
        2.3.2 Viral Vector Manufacturing Market Drivers
        2.3.3 Viral Vector Manufacturing Market Challenges
        2.3.4 Viral Vector Manufacturing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Viral Vector Manufacturing Players by Revenue
        3.1.1 Global Top Viral Vector Manufacturing Players by Revenue (2017-2022)
        3.1.2 Global Viral Vector Manufacturing Revenue Market Share by Players (2017-2022)
    3.2 Global Viral Vector Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Viral Vector Manufacturing Revenue
    3.4 Global Viral Vector Manufacturing Market Concentration Ratio
        3.4.1 Global Viral Vector Manufacturing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Manufacturing Revenue in 2021
    3.5 Viral Vector Manufacturing Key Players Head office and Area Served
    3.6 Key Players Viral Vector Manufacturing Product Solution and Service
    3.7 Date of Enter into Viral Vector Manufacturing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector Manufacturing Breakdown Data by Type
    4.1 Global Viral Vector Manufacturing Historic Market Size by Type (2017-2022)
    4.2 Global Viral Vector Manufacturing Forecasted Market Size by Type (2023-2028)
5 Viral Vector Manufacturing Breakdown Data by Application
    5.1 Global Viral Vector Manufacturing Historic Market Size by Application (2017-2022)
    5.2 Global Viral Vector Manufacturing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Viral Vector Manufacturing Market Size (2017-2028)
    6.2 North America Viral Vector Manufacturing Market Size by Country (2017-2022)
    6.3 North America Viral Vector Manufacturing Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Viral Vector Manufacturing Market Size (2017-2028)
    7.2 Europe Viral Vector Manufacturing Market Size by Country (2017-2022)
    7.3 Europe Viral Vector Manufacturing Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Viral Vector Manufacturing Market Size (2017-2028)
    8.2 Asia-Pacific Viral Vector Manufacturing Market Size by Country (2017-2022)
    8.3 Asia-Pacific Viral Vector Manufacturing Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Viral Vector Manufacturing Market Size (2017-2028)
    9.2 Latin America Viral Vector Manufacturing Market Size by Country (2017-2022)
    9.3 Latin America Viral Vector Manufacturing Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Viral Vector Manufacturing Market Size (2017-2028)
    10.2 Middle East & Africa Viral Vector Manufacturing Market Size by Country (2017-2022)
    10.3 Middle East & Africa Viral Vector Manufacturing Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 BioReliance
        11.1.1 BioReliance Company Detail
        11.1.2 BioReliance Business Overview
        11.1.3 BioReliance Viral Vector Manufacturing Introduction
        11.1.4 BioReliance Revenue in Viral Vector Manufacturing Business (2017-2022)
        11.1.5 BioReliance Recent Development
    11.2 Cobra Biologics
        11.2.1 Cobra Biologics Company Detail
        11.2.2 Cobra Biologics Business Overview
        11.2.3 Cobra Biologics Viral Vector Manufacturing Introduction
        11.2.4 Cobra Biologics Revenue in Viral Vector Manufacturing Business (2017-2022)
        11.2.5 Cobra Biologics Recent Development
    11.3 Oxford BioMedica
        11.3.1 Oxford BioMedica Company Detail
        11.3.2 Oxford BioMedica Business Overview
        11.3.3 Oxford BioMedica Viral Vector Manufacturing Introduction
        11.3.4 Oxford BioMedica Revenue in Viral Vector Manufacturing Business (2017-2022)
        11.3.5 Oxford BioMedica Recent Development
    11.4 UniQure
        11.4.1 UniQure Company Detail
        11.4.2 UniQure Business Overview
        11.4.3 UniQure Viral Vector Manufacturing Introduction
        11.4.4 UniQure Revenue in Viral Vector Manufacturing Business (2017-2022)
        11.4.5 UniQure Recent Development
    11.5 FinVector
        11.5.1 FinVector Company Detail
        11.5.2 FinVector Business Overview
        11.5.3 FinVector Viral Vector Manufacturing Introduction
        11.5.4 FinVector Revenue in Viral Vector Manufacturing Business (2017-2022)
        11.5.5 FinVector Recent Development
    11.6 MolMed
        11.6.1 MolMed Company Detail
        11.6.2 MolMed Business Overview
        11.6.3 MolMed Viral Vector Manufacturing Introduction
        11.6.4 MolMed Revenue in Viral Vector Manufacturing Business (2017-2022)
        11.6.5 MolMed Recent Development
    11.7 MassBiologics
        11.7.1 MassBiologics Company Detail
        11.7.2 MassBiologics Business Overview
        11.7.3 MassBiologics Viral Vector Manufacturing Introduction
        11.7.4 MassBiologics Revenue in Viral Vector Manufacturing Business (2017-2022)
        11.7.5 MassBiologics Recent Development
    11.8 FUJIFILM Diosynth Biotechnologies
        11.8.1 FUJIFILM Diosynth Biotechnologies Company Detail
        11.8.2 FUJIFILM Diosynth Biotechnologies Business Overview
        11.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing Introduction
        11.8.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Business (2017-2022)
        11.8.5 FUJIFILM Diosynth Biotechnologies Recent Development
    11.9 Lonza
        11.9.1 Lonza Company Detail
        11.9.2 Lonza Business Overview
        11.9.3 Lonza Viral Vector Manufacturing Introduction
        11.9.4 Lonza Revenue in Viral Vector Manufacturing Business (2017-2022)
        11.9.5 Lonza Recent Development
    11.10 Biovian
        11.10.1 Biovian Company Detail
        11.10.2 Biovian Business Overview
        11.10.3 Biovian Viral Vector Manufacturing Introduction
        11.10.4 Biovian Revenue in Viral Vector Manufacturing Business (2017-2022)
        11.10.5 Biovian Recent Development
    11.11 Thermo Fisher Scientific (Brammer Bio)
        11.11.1 Thermo Fisher Scientific (Brammer Bio) Company Detail
        11.11.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
        11.11.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Manufacturing Introduction
        11.11.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Manufacturing Business (2017-2022)
        11.11.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Viral Vector Manufacturing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Adenoviral Vectors
    Table 3. Key Players of Adeno-associated Viral Vectors
    Table 4. Key Players of Retroviral Vectors
    Table 5. Key Players of Lentiviral Vectors
    Table 6. Key Players of Other
    Table 7. Global Viral Vector Manufacturing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Viral Vector Manufacturing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Viral Vector Manufacturing Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Viral Vector Manufacturing Market Share by Region (2017-2022)
    Table 11. Global Viral Vector Manufacturing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Viral Vector Manufacturing Market Share by Region (2023-2028)
    Table 13. Viral Vector Manufacturing Market Trends
    Table 14. Viral Vector Manufacturing Market Drivers
    Table 15. Viral Vector Manufacturing Market Challenges
    Table 16. Viral Vector Manufacturing Market Restraints
    Table 17. Global Viral Vector Manufacturing Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Viral Vector Manufacturing Market Share by Players (2017-2022)
    Table 19. Global Top Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Manufacturing as of 2021)
    Table 20. Ranking of Global Top Viral Vector Manufacturing Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Viral Vector Manufacturing Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Viral Vector Manufacturing Product Solution and Service
    Table 24. Date of Enter into Viral Vector Manufacturing Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Viral Vector Manufacturing Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Viral Vector Manufacturing Revenue Market Share by Type (2017-2022)
    Table 28. Global Viral Vector Manufacturing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Viral Vector Manufacturing Revenue Market Share by Type (2023-2028)
    Table 30. Global Viral Vector Manufacturing Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Viral Vector Manufacturing Revenue Market Share by Application (2017-2022)
    Table 32. Global Viral Vector Manufacturing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Viral Vector Manufacturing Revenue Market Share by Application (2023-2028)
    Table 34. North America Viral Vector Manufacturing Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Viral Vector Manufacturing Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Viral Vector Manufacturing Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Viral Vector Manufacturing Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Viral Vector Manufacturing Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Viral Vector Manufacturing Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Viral Vector Manufacturing Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Viral Vector Manufacturing Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Viral Vector Manufacturing Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Viral Vector Manufacturing Market Size by Country (2023-2028) & (US$ Million)
    Table 44. BioReliance Company Detail
    Table 45. BioReliance Business Overview
    Table 46. BioReliance Viral Vector Manufacturing Product
    Table 47. BioReliance Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 48. BioReliance Recent Development
    Table 49. Cobra Biologics Company Detail
    Table 50. Cobra Biologics Business Overview
    Table 51. Cobra Biologics Viral Vector Manufacturing Product
    Table 52. Cobra Biologics Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 53. Cobra Biologics Recent Development
    Table 54. Oxford BioMedica Company Detail
    Table 55. Oxford BioMedica Business Overview
    Table 56. Oxford BioMedica Viral Vector Manufacturing Product
    Table 57. Oxford BioMedica Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 58. Oxford BioMedica Recent Development
    Table 59. UniQure Company Detail
    Table 60. UniQure Business Overview
    Table 61. UniQure Viral Vector Manufacturing Product
    Table 62. UniQure Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 63. UniQure Recent Development
    Table 64. FinVector Company Detail
    Table 65. FinVector Business Overview
    Table 66. FinVector Viral Vector Manufacturing Product
    Table 67. FinVector Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 68. FinVector Recent Development
    Table 69. MolMed Company Detail
    Table 70. MolMed Business Overview
    Table 71. MolMed Viral Vector Manufacturing Product
    Table 72. MolMed Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 73. MolMed Recent Development
    Table 74. MassBiologics Company Detail
    Table 75. MassBiologics Business Overview
    Table 76. MassBiologics Viral Vector Manufacturing Product
    Table 77. MassBiologics Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 78. MassBiologics Recent Development
    Table 79. FUJIFILM Diosynth Biotechnologies Company Detail
    Table 80. FUJIFILM Diosynth Biotechnologies Business Overview
    Table 81. FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing Product
    Table 82. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 83. FUJIFILM Diosynth Biotechnologies Recent Development
    Table 84. Lonza Company Detail
    Table 85. Lonza Business Overview
    Table 86. Lonza Viral Vector Manufacturing Product
    Table 87. Lonza Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 88. Lonza Recent Development
    Table 89. Biovian Company Detail
    Table 90. Biovian Business Overview
    Table 91. Biovian Viral Vector Manufacturing Product
    Table 92. Biovian Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 93. Biovian Recent Development
    Table 94. Thermo Fisher Scientific (Brammer Bio) Company Detail
    Table 95. Thermo Fisher Scientific (Brammer Bio) Business Overview
    Table 96. Thermo Fisher Scientific (Brammer Bio) Viral Vector ManufacturingProduct
    Table 97. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Manufacturing Business (2017-2022) & (US$ Million)
    Table 98. Thermo Fisher Scientific (Brammer Bio) Recent Development
    Table 99. Research Programs/Design for This Report
    Table 100. Key Data Information from Secondary Sources
    Table 101. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Viral Vector Manufacturing Market Share by Type: 2021 VS 2028
    Figure 2. Adenoviral Vectors Features
    Figure 3. Adeno-associated Viral Vectors Features
    Figure 4. Retroviral Vectors Features
    Figure 5. Lentiviral Vectors Features
    Figure 6. Other Features
    Figure 7. Global Viral Vector Manufacturing Market Share by Application in 2021 & 2028
    Figure 8. Gene Therapy Case Studies
    Figure 9. Vaccinology Case Studies
    Figure 10. Viral Vector Manufacturing Report Years Considered
    Figure 11. Global Viral Vector Manufacturing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Viral Vector Manufacturing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Viral Vector Manufacturing Market Share by Region: 2021 VS 2028
    Figure 14. Global Viral Vector Manufacturing Market Share by Players in 2021
    Figure 15. Global Top Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Manufacturing as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Viral Vector Manufacturing Revenue in 2021
    Figure 17. North America Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Viral Vector Manufacturing Market Share by Country (2017-2028)
    Figure 19. United States Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Viral Vector Manufacturing Market Share by Country (2017-2028)
    Figure 23. Germany Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Viral Vector Manufacturing Market Share by Region (2017-2028)
    Figure 31. China Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Viral Vector Manufacturing Market Share by Country (2017-2028)
    Figure 39. Mexico Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Viral Vector Manufacturing Market Share by Country (2017-2028)
    Figure 43. Turkey Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Viral Vector Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. BioReliance Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022)
    Figure 46. Cobra Biologics Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022)
    Figure 47. Oxford BioMedica Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022)
    Figure 48. UniQure Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022)
    Figure 49. FinVector Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022)
    Figure 50. MolMed Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022)
    Figure 51. MassBiologics Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022)
    Figure 52. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022)
    Figure 53. Lonza Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022)
    Figure 54. Biovian Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022)
    Figure 55. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vector Manufacturing Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
FUJIFILM Diosynth Biotechnologies
Lonza
Biovian
Thermo Fisher Scientific (Brammer Bio)
Frequently Asked Questions
Viral Vector Manufacturing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Viral Vector Manufacturing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Viral Vector Manufacturing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Optometry Equipment

Optometry is a health care profession which involves examining the eyes and applicable visual sys ... Read More